Infinity Pharmaceuticals News

Infinity Pharmaceuticals Inc -- USA Stock  

USD 1.86  0.01  0.53%

Macroaxis does not monitor all media channels or aggregates social signals for Infinity Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Infinity Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Infinity Pharmaceuticals. Please also check Infinity Pharmaceuticals Hype Analysis, Infinity Pharmaceuticals Correlation and Infinity Pharmaceuticals Performance
  
2 days ago at bzweekly.com         
Infinity Pharmaceuticals, Inc. EPS Estimated At -0.25
news
BZ WeeklyFavorable Media Coverage Somewhat Unlikely to Impact Infinity Pharmaceuticals Stock Price The Ledger GazetteInfinity Pharmaceuticals, Inc. Analysts See -0.25 EPS Frisco Fastball Get full coverage
  
  
3 days ago at postanalyst.com         
Lets Take Some Time To Look Back United States Steel Corporation , Infinity Pharmaceuticals, Inc.
news
Post Analyst Get full coverage
  
  
few days ago at kldaily.com         
Biotechnology Value Fund LP Opened Huge Infinity Pharmaceuticals, Inc Position
news
KL DailyInfinity Pharmaceuticals, Inc. Analysts See -0.25 EPS Frisco FastballThere Is Something To Be Excited About Infinity Pharmaceuticals, Inc. , Zynga Inc. Post Analyst Get full coverage
  
  
few days ago at www.wallstreetmorning.com         
Investors watching Technical Indicators on Infinity Pharmaceuticals, Inc.
news
Technical analysis of Infinity Pharmaceuticals, Inc. stock includes the study of technical indicators and past trends.
  
  
few days ago at factsreporter.com         
Hot Stock to Watch Infinity Pharmaceuticals, Inc.
news
FactsReporterInfinity Pharmaceuticals, Inc. A Detailed Look at its Institutional Ownership Post AnalystInfinity Pharmaceuticals Incorporated on Focus After Report of Less Shorts BZ Weekly Get full coverage
  
  
six days ago at economicsandmoney.com         
Choosing Between Novavax, Inc. and Infinity Pharmaceuticals, Inc.
news
Novavax, Inc. and Infinity Pharmaceuticals, Inc. are both Healthcare companies that recently hit new highs.
  
  
over a week ago at utahherald.com         
Analysts See -0.25 EPS for Infinity Pharmaceuticals, Inc. Last Week Active Energy Group PLC LONAEG ....
news
UtahHerald.comInfinity Pharmaceuticals Given Daily Media Impact Score of 0.11 Dispatch TribunalAs Gilead Sciences Shares Declined, Monarch Capital Management Has Raised Holding by 321975 Platinum ... Herald KS Get full coverage
  
  
over a week ago at www.mmahotstuff.com         
Infinity Pharmaceuticals, Inc. EPS Estimated At -0.25 Xencor ...
news
Analysts expect Infinity Pharmaceuticals, Inc. to report -0.25 EPS on March, 13.They anticipate 0.21 EPS change or 45.65 percent from last quarter -0.46 EPS. General Electric Co Shareholder Lakeview Capital Partners Decreased Its ... - Thorold News Carlson Capital Management Holding in Apple Decreased as Share Price ... - NormanObserver.com
  
  
over a week ago at weekherald.com         
Clear Harbor Asset Management LLC Takes Position in Infinity Pharmaceuticals ...
news
Infinity Pharmaceuticals logo Clear Harbor Asset Management LLC acquired a new position in Infinity Pharmaceuticals Inc. in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. EPS for Infinity Pharmaceuticals, Inc. Expected At -0.25 Hawaiian ... - UtahHerald.com Infinity Pharmaceuticals, Inc. Reaches 2.08 After 7.00 percent Up Move Tenet ... - NormanObserver.com
  
  
over a week ago at www.prnewswire.com         
Infinity To Present At BIO CEO and Investor Conference
prnewswire News
CAMBRIDGE, Mass., Feb. 5, 2018 PRNewswire -- Infinity Pharmaceuticals, Inc. announced today that Adelene Perkins, Infinity Pharmaceutical chief executive officer, will present at the BIO CEO and Investor Conference on Monday, February ...
  
  
over two weeks ago at www.macroaxis.com         
Infinity Pharmaceuticals exotic insider transaction detected
Macroaxis News
Filed transaction by Infinity Pharmaceuticals officer. Unconventional Insider trading
  
  
over two weeks ago at earlebusinessunion.com         
Are Investors Rallying Behind Infinity Pharmaceuticals, Inc. NasdaqGSINFI ...
news
The Return on Invested Capital Score for Infinity Pharmaceuticals, Inc. is -1.261285. The Return on Invested Capital is a ratio that determines whether a company is profitable or not.
  
  
over two weeks ago at postanalyst.com         
Analysts Shared Their Read on 2 Stocks Altria Group, Inc. , Infinity ...
news
Altria Group, Inc. has made its way to a 12-month decline of -1.18. Turning to Infinity Pharmaceuticals, Inc. , its shares were trading at 2.05 a retreat of -0.01, on the trading floor.
  
  
over two weeks ago at postanalyst.com         
Should You Buy At This Valuation Affimed NV , Infinity Pharmaceuticals, Inc.
news
Post AnalystWhat Analysts Say Infinity Pharmaceuticals, Inc. stock closes Yesterday with -3.74 Nasdaq Fortune Infinity Pharmaceuticals Receiving Somewhat Positive Press Coverage, Analysis Shows The Lincolnian Online Get full coverage
  
  
over two weeks ago at aikenadvocate.com         
Shooting From The Hip Quant Update on Infinity Pharmaceuticals, Inc ...
news
We can also take a look at some stock volatility data on shares of Infinity Pharmaceuticals, Inc. . The 12 month volatility is currently 100.668400.
  

Contributor Headline

Latest Prospective on Infinity Pharmaceuticals
Infinity Pharmaceuticals
  over two weeks ago at Macroaxis
Filed for Tasker Seth A
Great Plains exotic insider transaction detected
February 18, 2018 for Chesser Michael J
Purchase by Robert Vogels of 25000 shares of Golden Minerals
February 18, 2018 for Robert Vogels
View All Premium Stories  
Price Growth (%)  
      Timeline 

Earnings

Infinity Pharmaceuticals Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.56February 28, 2017
Infinity Pharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Pair Trading

Infinity Pharmaceuticals Pair Trading Analysis
Correlation analysis and pair trading evaluation for Infinity Pharmaceuticals and NantKwest Inc. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Total Debt

Infinity Pharmaceuticals Total Debt
Based on latest financial disclosure Infinity Pharmaceuticals Inc has Total Debt of 6 M. This is 99.75% lower than that of the Healthcare sector, and significantly higher than that of Pharmaceutical Products industry, The Total Debt for all stocks is 99.92% higher than the company.
In most industries, total debt may also include current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meaningful to compare total debt amounts between companies that operate within the same sector.